Tirzepatide, the novel medication, is sparking considerable interest within the scientific community. It operates differently from existing diabetes treatments , targeting two receptors involved in blood regulation and appetite . Initial studies have demonstrated remarkable efficacy in lowering blood glucose in individuals with type 2 diabetes and,